Abstract
This article reports the microwave-assisted synthesis, characterization, and evaluation of some-4-one derivatives (2a-2h) for their in-vitro antimycobacterial activities against Mycobacterium tuberculosis H37Rv strain by microplate Alamar blue assay (MABA) method. All these final compounds (2a-2h) were synthesized from Schiff’s bases, 1-arylidene-2-(4-methylphenyl)hydrazines (1a-1h), and thioglycolic acid by using zinc chloride as a catalyst. Compounds (1a-1h) were synthesized from the reaction of 4-methylhydrazine and appropriate aromatic aldehydes by Schiff’s reaction. Among the target compounds, 2-(4-ethoxyphenyl)-3-(4-methylarylamino)thiazolidin-4-one (2f) and 2-(4-ethylphenyl)-3-(4-methylarylamino)thiazolidin-4-one (2g) were promising with a minimum inhibitory concentration (MIC) of 12.5 μg/mL against M. tuberculosisH37Rv. Based on the preliminary results, compounds 2f and 2g were considered lead compounds for the advanced design and development of antimycobacterial agents.
Keywords: Antimycobacterial, heterocyclic, microwave-assisted synthesis, tuberculosis, 4-thiazolidinone.
Graphical Abstract
[http://dx.doi.org/10.1021/co100034v] [PMID: 21247130]
[http://dx.doi.org/10.1016/j.ejmech.2013.11.017] [PMID: 24355348]
[http://dx.doi.org/10.2174/1570179415666180919125625]
[http://dx.doi.org/10.3109/14756366.2012.732071] [PMID: 23173744]
[http://dx.doi.org/10.1016/j.ejmech.2013.01.054] [PMID: 23567949]
[http://dx.doi.org/10.1016/j.ejmech.2007.07.017] [PMID: 17870209]
[http://dx.doi.org/10.35333/jrp.2020.110]
[http://dx.doi.org/10.1080/00397911.2018.1564928]
[http://dx.doi.org/10.2174/1570180815666171229150032]
[http://dx.doi.org/10.1016/j.bmcl.2016.03.055] [PMID: 27017114]
[PMID: 25910087]
[http://dx.doi.org/10.1080/14756360802608021] [PMID: 19624255]
[http://dx.doi.org/10.1002/ardp.200900001] [PMID: 19899098]
[http://dx.doi.org/10.3998/ark.5550190.0008.f18]